PROCEPT BioRobotics Corporation
PRCT
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinaā¦ read more
Healthcare
Medical Devices
4 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$20.73
Price-5.39%
-$1.18
1Y
Price
Market Cap
$1.180b
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.-35.0%
EBITDA Margin-38.1%
Net Profit Margin-49.4%
Free Cash Flow Margin-35.0%
EBITDA Margin-38.1%
Net Profit Margin-49.4%
Free Cash Flow MarginRevenue
$322.024m
+4.5%
1y CAGR+35.5%
3y CAGR+47.0%
5y CAGREarnings
-$102.472m
-7.2%
1y CAGR+0.6%
3y CAGR-4.9%
5y CAGREPS
-$1.82
-5.8%
1y CAGR+5.9%
3y CAGR+0.9%
5y CAGRBook Value
$347.667m
$487.062m
Assets$139.395m
Liabilities$51.664m
DebtDebt to Assets
10.6%
-0.6x
Debt to EBITDAFree Cash Flow
-$80.566m
-38.1%
1y CAGR+9.3%
3y CAGR-8.1%
5y CAGRNo items found.
Press Releases
Statements and updates from the company